Literature DB >> 25728341

Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH.

D M Dimichele1, S Lacroix-Desmazes, F Peyvandi, A Srivastava, F R Rosendaal.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25728341     DOI： 10.1111/jth.12882

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  Bayesian approach to the assessment of the population-specific risk of inhibitors in hemophilia A patients: a case study.

Authors:  Ji Cheng; Alfonso Iorio; Maura Marcucci; Vadim Romanov; Eleanor M Pullenayegum; John K Marshall; Lehana Thabane
Journal:  J Blood Med       Date:  2016-10-25

2.  The prevalence and risk factors of inhibitor development of FVIII in previously treated patients with hemophilia A.

Authors:  Ju Young Kim; Chur Woo You
Journal:  Blood Res       Date:  2019-09-25

3.  Health-related quality of life of patients with haemophilia: a cross-sectional survey in the Northeast of China.

Authors:  Jinyu Niu; Liangwen Ning; Qiao Zhang; Ze Liu; Yi Ma; Xiaoxue Xu; Qunhong Wu; Yanhua Hao; Yu Cui; Chaojie Liu
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.